Neurocrine Biosciences
NBIX
#1648
Rank
S$12.83 B
Marketcap
$128.70
Share price
-7.03%
Change (1 day)
-30.64%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company